期刊文献+

普芦卡必利在机器人辅助腹腔镜根治性膀胱切除+尿流改道术围手术期应用的效果分析

Perioperative application of prucalopride in robot-assisted laparoscopic radical cystectomy and urinary diversion
下载PDF
导出
摘要 目的明确普芦卡必利(PRUC)在机器人辅助腹腔镜根治性膀胱切除(RARC)+尿流改道术围手术期对患者肠道功能的影响。方法回顾性分析2021年4—12月南京大学医学院附属鼓楼医院收治的75例行RARC+尿流改道术(原位膀胱术/回肠膀胱术)患者,根据围手术期是否服用PRUC分为PRUC组(28例)和常规组(47例)。分析比较两组患者术后肠道通气时间、通便时间、引流管留置时间、首次进食半流食物耐受时间、术后住院时间以及术后并发症的发生率,并比较两组患者术后C反应蛋白(CRP)和中性粒细胞/淋巴细胞比值(NLR)的变化。结果PRUC组较常规组患者肠道通气时间和通便时间均更短[(47.14±16.31)h vs.(74.04±35.33)h,P<0.01;(86.14±30.47)h vs.(123.57±79.12)h,P=0.02]。PRUC组较常规组术后CRP(ΔCRP)和NLR变化幅度(ΔNLR)均较小[(79.99±29.71)mg/L vs.(127.75±56.98)mg/L;(9.24±6.43)vs.(16.11±9.90),P均<0.01]。所有并发症均为次要并发症,PRUC组患者术后90 d内肠梗阻发生率有降低的趋势(P=0.38),两组间其他并发症差异均无统计学意义(P>0.05)。结论PRUC可促进RARC+尿流改道术患者术后肠道功能恢复。 Objective To explore the effects of prucalopride(PRUC)on the intestinal function during the perioperative period of robot-assisted laparoscopic radical cystectomy(RARC)and urinary diversion.Methods A total of 75 patients undertaking RARC with urinary diversion(orthotopic neobladder or ileal bladder)in Nanjing Drum Hospital during Jan.and Dec.2021 were divided into PRUC group(n=28)and control group(n=47)according to whether they took PRUC or not.Postoperative intestinal ventilation time and defecation time,drainage tube retention time,tolerance time for first intake of semi-flow food,postoperative hospital stay,and incidence of complications were observed and recorded in the two groups.Postoperative C-reactive protein(CRP)and neutrophil/lymphocyte ratio(NLR)were compared.Results The PRUC group had shorter intestinal ventilation time and defecation time[(47.14±16.31)h vs.(74.04±35.33)h,P<0.01;(86.14±30.47)h vs.(123.57±79.12)h,P=0.02],smaller change ofΔCRP andΔNLR[(79.99±29.71)mg/L vs.(127.75±56.98)mg/L;(9.24±6.43)vs.(16.11±9.90),P<0.01].All complications were minor,the incidence of intestinal obstruction in PRUC group tended to decrease within 90 days after operation(P=0.38),and there was no significant difference in other complications between the two groups(P>0.05).Conclusion The perioperative use of PRUC in RARC with urinary diversion is safe and effective,which can promote the recovery of intestinal function after operation.
作者 韦发昀 蒋宁 刘华英 冯宝富 张顺 丁佳蓉 甘卫东 张士伟 郭宏骞 杨荣 WEI Fayun;JIANG Ning;LIU Huaying;FENG Baofu;ZHANG Shun;DING Jiarong;GAN Weidong;ZHANG Shiwei;GUO Hongqian;YANG Rong(Department of Urology,Nanjing Drum Tower Hospital,Affiliated Hospital of Medical School,Nanjing University,Nanjing 210008;Nanjing Drum Tower Hospital Clinical College of Jiangsu University,Nanjing 210008;Department of Urology,Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine,Nanjing 210008;Department of Urology,The Affiliated Nanjing Drum Tower Hospital of Nanjing Medical University,Nanjing 210008,China)
出处 《现代泌尿外科杂志》 CAS 2024年第5期394-398,共5页 Journal of Modern Urology
基金 国家自然科学基金项目(No.82172691)。
关键词 膀胱癌 机器人辅助腹腔镜根治性膀胱切除 尿流改道 普芦卡必利 术后肠梗阻 肠道功能 围手术期 bladder cancer robot-assisted laparoscopic radical cystectomy urinary diversion prucalopride post-operative ileus intestinal function perioperative period
  • 相关文献

参考文献2

二级参考文献11

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部